Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Jerusalem Pharmaceuticals Statistics

Total Valuation

PEX:JPH has a market cap or net worth of JOD 51.05 million. The enterprise value is 41.94 million.

Market Cap	51.05M
Enterprise Value	41.94M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

PEX:JPH has 18.00 million shares outstanding.

Current Share Class	18.00M
Shares Outstanding	18.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 9.31.

PE Ratio	9.31
Forward PE	n/a
PS Ratio	1.63
PB Ratio	0.92
P/TBV Ratio	0.96
P/FCF Ratio	8.26
P/OCF Ratio	6.63
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.34, with an EV/FCF ratio of 6.79.

EV / Earnings	7.65
EV / Sales	1.34
EV / EBITDA	5.34
EV / EBIT	6.22
EV / FCF	6.79

Financial Position

The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.01.

Current Ratio	3.40
Quick Ratio	2.57
Debt / Equity	0.01
Debt / EBITDA	0.09
Debt / FCF	0.12
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 10.78% and return on invested capital (ROIC) is 8.09%.

Return on Equity (ROE)	10.78%
Return on Assets (ROA)	6.38%
Return on Invested Capital (ROIC)	8.09%
Return on Capital Employed (ROCE)	11.17%
Revenue Per Employee	59,021
Profits Per Employee	10,324
Employee Count	531
Asset Turnover	0.47
Inventory Turnover	1.98

Taxes

In the past 12 months, PEX:JPH has paid 1.41 million in taxes.

Income Tax	1.41M
Effective Tax Rate	20.47%

Stock Price Statistics

The stock price has increased by +8.99% in the last 52 weeks. The beta is 0.07, so PEX:JPH's price volatility has been lower than the market average.

Beta (5Y)	0.07
52-Week Price Change	+8.99%
50-Day Moving Average	3.96
200-Day Moving Average	3.80
Relative Strength Index (RSI)	49.54
Average Volume (20 Days)	1,943

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PEX:JPH had revenue of JOD 31.34 million and earned 5.48 million in profits. Earnings per share was 0.30.

Revenue	31.34M
Gross Profit	16.71M
Operating Income	6.74M
Pretax Income	6.91M
Net Income	5.48M
EBITDA	7.65M
EBIT	6.74M
Earnings Per Share (EPS)	0.30

Balance Sheet

The company has 10.57 million in cash and 717,591 in debt, giving a net cash position of 9.86 million or 0.55 per share.

Cash & Cash Equivalents	10.57M
Total Debt	717,591
Net Cash	9.86M
Net Cash Per Share	0.55
Equity (Book Value)	55.72M
Book Value Per Share	3.05
Working Capital	28.97M

Cash Flow

In the last 12 months, operating cash flow was 7.70 million and capital expenditures -1.51 million, giving a free cash flow of 6.18 million.

Operating Cash Flow	7.70M
Capital Expenditures	-1.51M
Free Cash Flow	6.18M
FCF Per Share	0.34

Margins

Gross margin is 53.32%, with operating and profit margins of 21.50% and 17.49%.

Gross Margin	53.32%
Operating Margin	21.50%
Pretax Margin	22.06%
Profit Margin	17.49%
EBITDA Margin	24.42%
EBIT Margin	21.50%
FCF Margin	19.72%

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 2.00%.

Dividend Per Share	0.06
Dividend Yield	2.00%
Dividend Growth (YoY)	-19.95%
Years of Dividend Growth	n/a
Payout Ratio	37.06%
Buyback Yield	n/a
Shareholder Yield	2.00%
Earnings Yield	10.74%
FCF Yield	12.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 1, 2013. It was a forward split with a ratio of 1.4216864044.

Last Split Date	Aug 1, 2013
Split Type	Forward
Split Ratio	1.4216864044

Scores

PEX:JPH has an Altman Z-Score of 3.55 and a Piotroski F-Score of 6.

Altman Z-Score	3.55
Piotroski F-Score	6